Skip to content

The effect of Frisian Flag GUM 456 (isomaltulose enriched and mineral and vitamin fortified) on cognitive performance parameters in young children.

The effect of Frisian Flag GUM 456 (isomaltulose enriched and mineral and vitamin fortified) on cognitive performance parameters in young children.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON21372
Enrollment
120
Registered
2011-05-11
Start date
2011-05-17
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy 5-6 year old children, memory and attention span will be studied

Interventions

1. A: Regular Growing up Milk
2. B : A + isomaltulose
3. C : B with double isomaltulose
4. D : B with mix of vitamins & minerals.

Sponsors

Fakultas Kedokteran Universitas Indonesia Fakultas Kedokteran Universitas Indonesia University of Indonesia Jl. Salemba Raya 4, Jakarta 10430, Indonesia
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Normal score on Wechsler Scales; 2. Hb within the normal range; 3. Average height; 4. Normal body weight; 5. Normal dietary pattern (food questionnaire); 6. Regular and easy milk consumption (2*200 ml per day).

Exclusion criteria

Exclusion criteria: Symptoms of or diagnosed for allergy, chronic infections, thyroid disorders, diabetes or lactose intolerance, and mental disturbances or retarded development.

Design outcomes

Primary

MeasureTime frame
Scores on memory and attention span during the first 180 minutes following the consumption of the test product.

Secondary

MeasureTime frame
Other markers of cognitive performance that come from the use of ANT test battery. Also antropometric measurements, height, weight, health questionaire, urine, heart rate.

Contacts

Public ContactAnne Schaafsma

P.O.Box 226

anne.schaafsma@frieslandcampina.com+31 (0)58 2992424

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)